17-80065575-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017950.4(CCDC40):​c.1531G>A​(p.Glu511Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00118 in 1,612,864 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E511Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0064 ( 10 hom., cov: 29)
Exomes 𝑓: 0.00064 ( 14 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

4
5
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 6.97

Publications

7 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010186464).
BP6
Variant 17-80065575-G-A is Benign according to our data. Variant chr17-80065575-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178709.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00642 (977/152208) while in subpopulation AFR AF = 0.0225 (935/41554). AF 95% confidence interval is 0.0213. There are 10 homozygotes in GnomAd4. There are 447 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC40NM_017950.4 linkc.1531G>A p.Glu511Lys missense_variant Exon 10 of 20 ENST00000397545.9 NP_060420.2 Q4G0X9-1
CCDC40NM_001243342.2 linkc.1531G>A p.Glu511Lys missense_variant Exon 10 of 18 NP_001230271.1 Q4G0X9-2
CCDC40NM_001330508.2 linkc.1531G>A p.Glu511Lys missense_variant Exon 10 of 11 NP_001317437.1 Q4G0X9-4
LOC124904074XR_007065931.1 linkn.305+5657C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkc.1531G>A p.Glu511Lys missense_variant Exon 10 of 20 5 NM_017950.4 ENSP00000380679.4 Q4G0X9-1

Frequencies

GnomAD3 genomes
AF:
0.00639
AC:
972
AN:
152090
Hom.:
10
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00155
AC:
385
AN:
247998
AF XY:
0.00106
show subpopulations
Gnomad AFR exome
AF:
0.0228
Gnomad AMR exome
AF:
0.000783
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000446
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000637
AC:
930
AN:
1460656
Hom.:
14
Cov.:
32
AF XY:
0.000557
AC XY:
405
AN XY:
726650
show subpopulations
African (AFR)
AF:
0.0229
AC:
765
AN:
33472
American (AMR)
AF:
0.000805
AC:
36
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52494
Middle Eastern (MID)
AF:
0.000351
AC:
2
AN:
5690
European-Non Finnish (NFE)
AF:
0.0000324
AC:
36
AN:
1111882
Other (OTH)
AF:
0.00142
AC:
86
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
55
111
166
222
277
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00642
AC:
977
AN:
152208
Hom.:
10
Cov.:
29
AF XY:
0.00601
AC XY:
447
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0225
AC:
935
AN:
41554
American (AMR)
AF:
0.00170
AC:
26
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5108
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68016
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00199
Hom.:
6
Bravo
AF:
0.00740
ESP6500AA
AF:
0.0240
AC:
102
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00196
AC:
237
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glu511Lys in exon 10 of CCDC40: This variant is not expected to have clinical si gnificance because it has been identified in 2.4% (102/4244) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs59978698). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Sep 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 15 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.40
.;T;.
Eigen
Pathogenic
0.69
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.91
D;D;D
MetaRNN
Benign
0.010
T;T;T
MetaSVM
Benign
-0.44
T
MutationAssessor
Pathogenic
3.0
M;M;M
PhyloP100
7.0
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-3.5
D;D;D
REVEL
Uncertain
0.33
Sift
Pathogenic
0.0
D;D;T
Sift4G
Benign
0.066
T;T;D
Polyphen
1.0
.;D;.
Vest4
0.73
MVP
0.71
MPC
0.76
ClinPred
0.047
T
GERP RS
5.1
Varity_R
0.52
gMVP
0.35
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59978698; hg19: chr17-78039374; COSMIC: COSV53898812; API